Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors

Cancer Genetics

Volumn 205, Issue 1-2, 2012, Pages 42-54

  Dougherty, Margaret J ^a   Tooke, Laura S ^a   Sullivan, Lisa M ^a   Hakonarson, Hakon ^a,b   Wainwright, Luanne M ^a   Biegel, Jaclyn A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain tumor; Neuroblastoma; Sarcoma; SNP array; Wilms tumor

Indexed keywords

ARTICLE; BENIGN TUMOR; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL EVALUATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DIAGNOSTIC TEST; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; GENE TRANSLOCATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPING; MICROARRAY ANALYSIS; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; TUMOR DIAGNOSIS;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MALE; MEDICAL ONCOLOGY; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIATRICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84860234497     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.01.014     Document Type: Article

References (19)

1. Miller D.T., Adam M.P., Aradhya S., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital abnormalities. Am J Hum Genet 2010, 86:749-764.
2. Dougherty M.J., Wilmoth D.M., Tooke L.S., et al. Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies. Cancer Genet 2011, 204:26-38.
3. Lindblad-Toh K., Tanenbaum D.M., Daly M.J., et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000, 18:1001-1005.
4. Mei R., Galipeau P.C., Prass C., et al. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 2000, 10:1126-1137.
5. Zhao X., Li C., Paez J.G., et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004, 64:3060-3071.
6. Zhao X., Weir B.A., LaFramboise T., et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 2005, 65:5561-5570.
7. Calhoun E.S., Hucl T., Gallmeier E., et al. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Cancer Res 2006, 66:7920-7928.
8. Gaasenbeek M., Howarth K., Rowan A.J., et al. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 2006, 66:3471-3479.
9. Monzon F.A., Hagenkord J.M., Lyons-Weiler M.A., et al. Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod Pathol 2008, 21:599-608.
10. Hagenkord J.M., Gatalica Z., Jonasch E., et al. Clinical genomics of renal epithelial tumors. Cancer Gen 2011, 204:285-297.
11. George R.E., Attiyeh E.F., Li S., et al. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One 2007, 2:e255.
12. Sievert A.J., Jackson E.M., Gai X., et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 2009, 19:449-458.
13. Peiffer D.A., Le J.M., Steemers F.J., et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006, 16:1136-1148.
14. Shaikh T.H., Gai X., Perin J.C., et al. High-resolution mapping of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009, 19:1670-1682.
15. Papenhausen P., Schwartz S., Risheg H., et al. UPD detection using homozygosity profiling with a SNP genotyping array. Am J Med Genet A 2011, 155A:757-768.
16. Hatada I., Ohashi H., Fukushima Y., et al. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 1996, 14:171-173.
17. McDonald J.M., Douglass E.C., Fisher R., et al. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 1998, 58:1387-1390.
18. Pfister S., Remke M., Castoldi M., et al. Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embyronal tumor with abundant neuropil and true rosettes. Acta Neuropathol 2009, 117:457-464.
19. Pasic I., Shilen A., Durbin A.D., et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 2010, 70:160-171.